Research Article
Comparison of Different Phenotypic Tests versus PCR in the Detection of Carbapenemase-Producing Pseudomonas aeruginosa Isolates in Hamadan, Iran
Table 2
The results of antibiogram testing for P. aeruginosa isolate.
| | Antibiotic | No. resistant (%) | Intermediate | Sensitive | Total |
| | Piperacillin | 42 (43.3) | 13 (13.4) | 42 (43.3) | 97 | | Piperacillin/tazobactam | 38 (39.2) | 11 (11.3) | 48 (49.4) | 97 | | Ceftazidime | 40 (41.2) | 6 (6.2) | 51 (52.6) | 97 | | Aztreonam | 50 (51.5) | 19 (19.5) | 28 (28.9) | 97 | | Amikacin | 40 (41.2) | 10 (10.3) | 47 (48.5) | 97 | | Ciprofloxacin | 53 (54.6) | 2 (2.1) | 42 (43.3) | 97 | | Meropenem | 40 (41.2) | 5 (5.2) | 52 (53.6) | 97 | | Doripenem | 45 (46.4) | 2 (2.1) | 50 (51.5) | 97 | | Cefoxitin | 92 (94.8) | 1 (1) | 4 (4.1) | 97 | | Tetracycline | 53 (54.6) | 5 (5.2) | 39 (40.2) | 97 | | Ceftriaxone | 65 (67) | 18 (18.6) | 14 (14.43) | 97 | | Imipenem | 48 (49.4) | 1 (1) | 48 (49.4) | 97 |
|
|
